Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:OSI_Pharmaceuticals
gptkb:Iveric_Bio |
| gptkbp:ceo |
gptkb:Kenji_Yasukawa
|
| gptkbp:employees |
around 17,000
|
| gptkbp:founded |
gptkb:2005
|
| gptkbp:global_presence |
over 70 countries
|
| gptkbp:headquarters |
gptkb:Tokyo,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Astellas
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:partnership |
gptkb:temple
gptkb:Bristol-Myers_Squibb gptkb:Pfizer gptkb:Merck_&_Co. |
| gptkbp:products |
oncology drugs
immunosuppressants urology drugs |
| gptkbp:research_focus |
neurology
infectious diseases transplantation urology |
| gptkbp:revenue |
over $10 billion
$12 billion (2022) |
| gptkbp:sustainability_initiatives |
gptkb:government_agency
social responsibility environmental responsibility |
| gptkbp:type |
gptkb:Company
|
| gptkbp:bfsParent |
gptkb:Immunocore
|
| gptkbp:bfsLayer |
4
|